Published in Arch Gen Psychiatry on April 01, 2008
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull (2009) 3.82
Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry (2010) 2.12
Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry (2012) 1.67
Mapping causal interregional influences with concurrent TMS-fMRI. Exp Brain Res (2008) 1.37
Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol (2010) 1.36
Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. Biol Psychiatry (2011) 1.22
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia. Schizophr Bull (2015) 0.95
Adjusting brain dynamics in schizophrenia by means of perceptual and cognitive training. PLoS One (2012) 0.93
D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia. Schizophr Bull (2012) 0.92
Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulation. Eur Arch Psychiatry Clin Neurosci (2012) 0.91
Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons. Biol Psychiatry (2015) 0.89
Electrophysiological assessment of auditory stimulus-specific plasticity in schizophrenia. Biol Psychiatry (2012) 0.88
Cognitive remediation in schizophrenia. Clin Psychopharmacol Neurosci (2012) 0.88
Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci (2014) 0.87
d-Cycloserine augmentation of cognitive remediation in schizophrenia. Schizophr Res (2014) 0.87
Perceptual training strongly improves visual motion perception in schizophrenia. Brain Cogn (2011) 0.86
Different mechanisms contributing to savings and anterograde interference are impaired in Parkinson's disease. Front Hum Neurosci (2013) 0.84
Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.83
Modulating neural plasticity with non-invasive brain stimulation in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.82
Impairments of motor-cortex responses to unilateral and bilateral direct current stimulation in schizophrenia. Front Psychiatry (2013) 0.82
A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation. Clin Neurophysiol (2016) 0.81
Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia. Front Psychol (2013) 0.81
What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit. Mol Psychiatry (2014) 0.81
Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation. Schizophr Bull (2014) 0.81
Kraepelin revisited: schizophrenia from degeneration to failed regeneration. Mol Psychiatry (2015) 0.79
Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging. Neuroscientist (2011) 0.79
Changes in plasticity across the lifespan: cause of disease and target for intervention. Prog Brain Res (2013) 0.79
Engagement with the auditory processing system during targeted auditory cognitive training mediates changes in cognitive outcomes in individuals with schizophrenia. Neuropsychology (2016) 0.78
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia. World Psychiatry (2013) 0.78
Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study. Neuropsychopharmacology (2014) 0.77
Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions. J Psychiatry Neurosci (2012) 0.77
Three dysconnectivity patterns in treatment-resistant schizophrenia patients and their unaffected siblings. Neuroimage Clin (2015) 0.76
Nonlinear parameters of surface EMG in schizophrenia patients depend on kind of antipsychotic therapy. Front Physiol (2015) 0.75
Induction of cortical plasticity for reciprocal muscles by paired associative stimulation. Brain Behav (2014) 0.75
A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation. Front Psychiatry (2016) 0.75
A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway. Brain Sci (2017) 0.75
Developmental restoration of LTP deficits in heterozygous CaMKIIα KO mice. J Neurophysiol (2016) 0.75
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol (2012) 6.78
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet (2012) 4.41
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet (2009) 3.52
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54
A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry (2011) 2.44
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res (2008) 2.38
Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol (2008) 2.10
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Short and long latency afferent inhibition in Parkinson's disease. Brain (2003) 2.02
Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry (2009) 2.01
The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol (2002) 1.92
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res (2006) 1.81
Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78
Effect of low-frequency repetitive transcranial magnetic stimulation on interhemispheric inhibition. J Neurophysiol (2005) 1.70
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. Blood (2012) 1.67
Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol (2002) 1.67
Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med (2012) 1.64
Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol (2004) 1.60
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain (2006) 1.53
Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry (2010) 1.51
Improving working memory: the effect of combining cognitive activity and anodal transcranial direct current stimulation to the left dorsolateral prefrontal cortex. Brain Stimul (2010) 1.50
Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev (2010) 1.49
N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis. Can J Neurol Sci (2012) 1.49
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep (2002) 1.48
Myoclonus. Continuum (Minneap Minn) (2013) 1.47
Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology (2013) 1.47
Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord (2010) 1.46
Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5. Crit Care Med (2013) 1.44
Clinical Management Updates in Mantle Cell Lymphoma. Oncology (Williston Park) (2016) 1.43
Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor. Ann Thorac Surg (2010) 1.42
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.40
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Two phases of short-interval intracortical inhibition. Exp Brain Res (2003) 1.37
Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry (2008) 1.33
Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol (2006) 1.31
Testing the limits: Investigating the effect of tDCS dose on working memory enhancement in healthy controls. Neuropsychologia (2013) 1.29
Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. J Psychiatry Neurosci (2010) 1.28
The use of tDCS and CVS as methods of non-invasive brain stimulation. Brain Res Rev (2007) 1.28
Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve (2006) 1.27
The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures. Mov Disord (2011) 1.27
Digit somatotopy within cortical areas of the postcentral gyrus in humans. Cereb Cortex (2008) 1.26
Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol (2002) 1.25
Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex (2007) 1.24
A review of the role of female gender in autism spectrum disorders. J Autism Dev Disord (2013) 1.24
Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease. Clin Neurophysiol (2011) 1.23
Neurophysiological evidence of error-monitoring deficits in patients with schizophrenia. Cereb Cortex (2002) 1.23
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophr Res (2008) 1.20
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord (2009) 1.20
Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies. Brain Res Rev (2009) 1.20
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. J Hematol Oncol (2014) 1.18
Improving working memory: exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex. Clin Neurophysiol (2011) 1.17
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol (2012) 1.16
Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol (2010) 1.16
Traumatic brain injury, major depression, and diffusion tensor imaging: making connections. Brain Res Rev (2010) 1.15
The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res (2006) 1.15
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
Intensity-dependent effects of 1 Hz rTMS on human corticospinal excitability. Clin Neurophysiol (2002) 1.15
Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum Brain Mapp (2010) 1.14
Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain (2010) 1.14
Investigating the cortical origins of motor overflow. Brain Res Brain Res Rev (2004) 1.14
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp (2009) 1.13
Dystonia in complex regional pain syndrome type I. Ann Neurol (2010) 1.13
Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology (2008) 1.12
The role of the corpus callosum in transcranial magnetic stimulation induced interhemispheric signal propagation. Biol Psychiatry (2010) 1.12
Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. Mov Disord (2009) 1.12
The effects of inhibitory and facilitatory intracortical circuits on interhemispheric inhibition in the human motor cortex. J Physiol (2007) 1.12
Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease. Brain (2011) 1.11
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul (2012) 1.10
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord (2008) 1.09
Cognitive function and brain structure in females with a history of adolescent-onset anorexia nervosa. Pediatrics (2008) 1.09
Cortical excitability and interhemispheric inhibition after subcortical pediatric stroke: plastic organization and effects of rTMS. Clin Neurophysiol (2010) 1.09
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord (2011) 1.09
Two phases of interhemispheric inhibition between motor related cortical areas and the primary motor cortex in human. Cereb Cortex (2008) 1.09
Transcranial magnetic stimulation in different current directions activates separate cortical circuits. J Neurophysiol (2010) 1.08
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex (2009) 1.08
Repetitive transcranial magnetic stimulation for pain: is it too early to standardise repetitive transcranial magnetic stimulation protocols? Pain (2016) 1.08
Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med (2004) 1.08
Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) (2002) 1.07
Combined scalp-thalamic EEG recording in sleep and epilepsy. Clin Neurophysiol (2002) 1.07
Investigating the Role of Current Strength in tDCS Modulation of Working Memory Performance in Healthy Controls. Front Psychiatry (2011) 1.07
Reward processing in anorexia nervosa. Neuropsychologia (2012) 1.06
Reduced cerebellar inhibition in schizophrenia: a preliminary study. Am J Psychiatry (2005) 1.05